Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Utility, validity, feasibility and acceptability of a clinician-administered depression, two-question screening tool for routine multiple sclerosis clinic administration.
Dynamic characterization of pathological and functional deterioration in a mouse model of optic neuritis related to neuromyelitis optica spectrum disorder.
Acute Water Intoxication Leading to Dilutional Hyponatremia in a Patient With Urinary Tract Infection: A Case Report.
MOGAD-Associated Recurrent Optic Neuritis Unresponsive to Corticosteroids: Clinical, Visual Field, and OCT Correlation.
Burden of 292 causes of death and life expectancy decomposition in Iran, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
Relevance of serum neurofilament light chain determination as a biomarker in multiple sclerosis. Consensus of the Spanish Society of Neurology's Study Group on Multiple Sclerosis and Related Neuroimmune Diseases.
Proteomic Biomarker Discovery in Cerebrospinal Fluid Identifies CD74 and CD14 for Differentiating Multiple Sclerosis from Neuromyelitis Optica.
The cascade to pathogenicity in autoantibody-mediated CNS diseases.
Lymphomatosis Cerebri Presenting as Steroid-Refractory Demyelinating Disease: A Diagnostic Challenge.
TIM-3-dependent lysosome biogenesis is required for myelin debris clearance in macrophages.
Use of semaglutide and tirzepatide among people with multiple sclerosis.
Differential Roles of IL-18 and IL-8 Gene Variations in Multiple Sclerosis: Associations with Susceptibility and MRI Disease Activity.
Corrigendum to 'Diagnostic adjudication of potential participants with chronic inflammatory demyelinating polyradiculoneuropathy in the ADHERE trial of subcutaneous efgartigimod PH20' [Journal of the Neurological Sciences, 486 (2026) 125918].
Imaging progenitor cell differentiation during central nervous system remyelination using an MRI gene reporter.
Ultrastructural analysis of human uncinate fasciculus with coherent anti-Stokes Raman spectroscopy.
Restless Legs Syndrome in Patients With PMP22-Related Neuropathies.
Investigation into the metabolomic effects of the non-canonical amino acid azetidine-2-carboxylic acid in neuroblastoma cells.
Reinitiating ocrelizumab with a full 600 mg dose after extended treatment interruption: No increased risk of infusion-related reactions.
The exercise hormone irisin has neuroprotective effects in a mouse model of multiple sclerosis.
Progressive disability but survival advantage in anti-Hu/ANNA1 paraneoplastic neurological syndromes.
Disability profiles in progressive multiple sclerosis reflect pathology distribution, independent of clinical phenotype.
Patient profiling in relapsing multiple sclerosis: insights from a real-world observational study into the unmet medical needs of patients on disease-modifying therapy.
Mutation in RNF170 Causes Unsteady Gait with Hypertrophic Olivary Degeneration.
Frequency of MRI abnormalities in adult-onset MOG-IgG-associated disease at disease presentation: A cohort of Latin American patients.
A novel limited-dose C5 inhibitor add-on as rescue therapy for refractory NMOSD attacks: a practical alternative to conventional multi-dose regimens.

Pages